The U.S. Patent and Trademark Office and the Center for Innovation Policy at Duke University are co-sponsoring a conference on patent quality. The conference will be held at USPTO headquarters in Alexandria, VA on December 13, 2016. Michelle Lee, Director and Valencia Martin Wallace, Deputy Commissioner for Patent Quality, will host the conference, which will have presentations on prosecution clarity, quality metrics, prosecution ethics, the effects of post-grant review on quality, international aspects, and applicants’ role in enhancing quality. Full details can be found here.
Contributors
Juristat #4 Overall Rank
Contact the Docs
Foreign Correspondents
Docs on Twitter
Recent Posts
- IPO & Harrity Analytics Release List of Top 300 Patent Holders for 2021
- Conference & CLE Calendar
- Webinar on Damage Calculations in Canadian IP Infringement Cases
- Webinar on Patent Activity and Trends in Emerging Markets
- Sigma-Aldrich Files Substantive Preliminary Motion 1 to Change the Count in Interference No. 106,133
- Top Three Stories of 2021
- IPO Webinar Provides 2021 Year-End Case Law Review
- BIO IPCC Webinar Series
- IPO Webinar Provides 2021 PTAB Year in Review
- CVC Files Substantive Miscellaneous Motion No. 4 to Add Senior Party Patents and Designate Claims Corresponding to the Count
Disclaimer
- "Patent Docs" does not contain any legal advice whatsoever. This weblog is for informational purposes only, and its publication does not create an attorney-client relationship. In addition, nothing on "Patent Docs" constitutes a solicitation for business. This weblog is intended primarily for other attorneys. Moreover, "Patent Docs" is the personal weblog of the Authors; it is not edited by the Authors' employers or clients and, as such, no part of this weblog may be so attributed. All posts on "Patent Docs" should be double-checked for their accuracy and current applicability.
Juristat #8 Overall Rank
- Powered By Invesp
« Guest Post -- The Emergent Microbiome: A Revolution for the Life Sciences -- Part IX, The Microbiome and Immunotherapy II | Main | PTAB Life Sciences Report -- Part I »
December 07, 2016
The comments to this entry are closed.
January 2022
Categories
- Best Mode (2)
- Biosimilars (237)
- Biotech/Pharma Business (174)
- Biotech/Pharma News (270)
- Board of Patent Appeals and Interferences (12)
- Claim Construction (94)
- Conferences & CLE's (2723)
- Court Report (507)
- Damages (35)
- Definiteness (24)
- District Court (212)
- Double Patenting (29)
- Enablement (30)
- Federal Circuit (927)
- Food and Drug Administration (99)
- Hatch-Waxman (86)
- Inequitable Conduct (52)
- Infringement - Contributory or Induced (23)
- Infringement - Literal or DOE (86)
- Injunction (32)
- International IP (269)
- Inventorship (14)
- Licensing (128)
- Media Commentary (61)
- Miscellaneous (153)
- News from Abroad (102)
- Novelty (66)
- Obviousness (203)
- Patent Exhaustion (3)
- Patent Legislation (299)
- Patent Litigation (214)
- Patent Office Rules & Procedures (794)
- Patent Profiles (104)
- Patent Prosecution (85)
- Patent Prosecution - International (26)
- Patent Research (4)
- Patent Trial and Appeal Board (310)
- Patentable Subject Matter (613)
- Personalized Medicine (5)
- Post-Grant Proceedings (151)
- PTAB Report (9)
- Study/Report (5)
- Supreme Court (233)
- Tools (5)
- Trade Secrets (10)
- Utility (4)
- Venue (11)
- Written Description (77)
Patent Resources
Patent Search
- Patent Search
Patent Blogs & Sites
- 717 Madison Place
- America-Israel Patent Law
- Anticipate This!
- BlawgIT
- Chicago IP Litigation Blog
- FedCircuitBlog
- Global Patent Quality
- Innovation Alliance
- Intellectual Property Watch
- IP Dragon
- IPcopy
- McCabe Ali LLP
- IPWatchdog.com
- Life Science IP
- Orange Book Blog
- Patent Blurb
- Patently-O
- Patentology
- Patents4Life
- Reexamination Center
- Intellepedia – IP News Center
- SPICY IP
Comments